Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function
Authors
Keywords
-
Journal
Nutrients
Volume 14, Issue 10, Pages 2152
Publisher
MDPI AG
Online
2022-05-21
DOI
10.3390/nu14102152
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Benefits, toxicity and current market of cannabidiol in edibles
- (2022) Gonzalo Astray et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Adipose Tissue Inflammation and Cardiovascular Disease: An Update
- (2022) Mariam N. Rana et al. Current Diabetes Reports
- Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners
- (2022) Owen S. Miller et al. EPILEPSY & BEHAVIOR
- What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?
- (2021) Piotr Schulz et al. Nutrients
- Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment
- (2021) Klaudia Berk et al. Journal of Clinical Medicine
- Comparison of Five Oral Cannabidiol Preparations in Adult Humans: Pharmacokinetics, Body Composition, and Heart Rate Variability
- (2021) Natasha N. Bondareva Williams et al. Pharmaceuticals
- Impact of excipient emulsions made from different types of oils on the bioavailability and metabolism of curcumin in gastrointestinal tract
- (2021) Haiyan Luo et al. FOOD CHEMISTRY
- Pharmacokinetic Investigation of Commercially Available Edible Marijuana Products in Humans: Potential Influence of Body Composition and Influence on Glucose Control
- (2021) Taylor Russell Ewell et al. Pharmaceuticals
- The current understanding of the benefits, safety, and regulation of cannabidiol in consumer products
- (2021) Jinpeng Li et al. FOOD AND CHEMICAL TOXICOLOGY
- Lipid-based formulations to increase cannabidiol bioavailability: In vitro digestion tests, pre-clinical assessment and clinical trial
- (2021) Manuel A.A. De Prá et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects
- (2020) Julie Crockett et al. EPILEPSIA
- The Effect of Medium Chain and Long Chain Triglycerides Incorporated in Self-Nano Emulsifying Drug Delivery Systems on Oral Absorption of Cannabinoids in Rats
- (2020) Dvora Izgelov et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome
- (2020) Ian Miller et al. JAMA Neurology
- Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
- (2020) Patrycja Bielawiec et al. Frontiers in Endocrinology
- Evaluation of pharmacokinetics and acute anti‐inflammatory potential of two oral cannabidiol preparations in healthy adults
- (2020) Jack M. Hobbs et al. PHYTOTHERAPY RESEARCH
- The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations
- (2020) Valentina Franco et al. CLINICAL PHARMACOKINETICS
- Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase 1 Clinical Trial
- (2020) Paul B. Watkins et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers
- (2020) Dvora Izgelov et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Lower Postprandial Thermogenic Response to an Unprocessed Whole Food Meal Compared to an Iso-Energetic/Macronutrient Meal Replacement in Young Women: A Single-Blind Randomized Cross-Over Trial
- (2020) Alex E. Mohr et al. Nutrients
- Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity
- (2020) Patrycja Bielawiec et al. Biomolecules
- The Thermic Effect of Food: A Review
- (2019) Manuel Calcagno et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Use of sorbitol as pharmaceutical excipient in the present day formulations – issues and challenges for drug absorption and bioavailability
- (2019) Ranjeet Prasad Dash et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Chokeberry polyphenols preservation using spray drying: effect of encapsulation using maltodextrin and skimmed milk on their recovery following in vitro digestion
- (2019) Nada Ćujić-Nikolić et al. JOURNAL OF MICROENCAPSULATION
- A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb® Formulation Technology Improving the Oral Bioavailability of Cannabidiol in Healthy Subjects
- (2019) Katharina Knaub et al. MOLECULES
- Cannabidiol improves metabolic dysfunction in middle-aged diabetic rats submitted to a chronic cerebral hypoperfusion
- (2019) Maria Rosa Trentin Zorzenon et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Antioxidative and Anti-Inflammatory Properties of Cannabidiol
- (2019) Sinemyiz Atalay et al. Antioxidants
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabis in liver disorders
- (2018) Hemant Goyal et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Cannabinoid Delivery Systems for Pain and Inflammation Treatment
- (2018) Natascia Bruni et al. MOLECULES
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- (2018) Lesley Taylor et al. CNS DRUGS
- Influence of Sodium Glucose Co-Transporter 2 Inhibition On The Physiological Adaptation to Endurance Exercise Training
- (2018) Alissa A Newman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
- (2018) Sophie A. Millar et al. Frontiers in Pharmacology
- Food, gastrointestinal pH, and models of oral drug absorption
- (2017) Ahmad Y. Abuhelwa et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults
- (2017) Leandra Abarca-Gómez et al. LANCET
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
- (2016) Khalid A. Jadoon et al. DIABETES CARE
- Role of the endocannabinoid system in diabetes and diabetic complications
- (2015) G Gruden et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rapid Rehydration and Moderate Plasma Glucose Elevation by Fluid Containing Enzymatically Synthesized Glycogen
- (2011) Kei INAGAKI et al. JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
- Influence of Short-Term Consumption of the Caffeine-Free, Epigallocatechin-3-Gallate Supplement, Teavigo, on Resting Metabolism and the Thermic Effect of Feeding
- (2010) Mark C. Lonac et al. Obesity
- The endocannabinoid system in obesity and type 2 diabetes
- (2008) V. Di Marzo DIABETOLOGIA
- Influence of Ascorbic Acid on the Thermic Effect of Feeding in Overweight and Obese Adult Humans
- (2008) Sean A. Newsom et al. Obesity
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started